作者
Nada M Kamel,Alaa H Amin,Mostafa Adel Rabie,Shymaa Hatem,Ahmed M. El‐Dessouki,Asmaa Abdelkerim Mandour,Riham A. El‐Shiekh,Shaza H. Aly
摘要
Objectives Alzheimer’s disease (AD) is a major and growing neurodegenerative disorder characterized by progressive cognitive and functional decline. Accumulating evidence indicates that pathological tau is closely associated with disease progression and cognitive impairment, supporting tau-directed therapeutic strategies. Methods and Key findings This review provides a tau-centered mechanistic and translational synthesis of structurally defined phytocompounds, integrating evidence on kinase/phosphatase regulation, tau post-translational modifications, aggregation and propagation, autophagy-mediated clearance, neuroinflammation, oxidative stress, mitochondrial dysfunction, gut–brain signaling, and epigenetic regulation. Unlike reviews that mainly catalogue natural products with anti-Alzheimer activity, we distinguish direct tau-related effects from broader neuroprotective actions and critically consider evidence from biochemical, computational, cellular, animal, and available clinical studies. Major translational barriers, including poor solubility, metabolic instability, limited bioavailability, and insufficient blood–brain barrier penetration, are also discussed, together with nanocarrier-based strategies developed to improve brain delivery. Natural phytocompounds, including flavonoids, polyphenols, stilbenes, terpenoids, and alkaloids, have shown potential to modulate tau-related pathology through multiple mechanisms. Conclusions By linking molecular mechanisms with experimental evidence and delivery considerations, this review highlights both the therapeutic promise and the remaining challenges of phytocompounds as modulators of tau pathology in AD.